Hong Kong Hot Stock: Analysis of Grand Health International (02211.HK)

Grand Health International (02211.HK) is a Hong Kong-listed company in the healthcare (pharmaceutical retail) sector. It appeared on the Hong Kong Stock Surge List of the East Money App at 16:30 (UTC+8) on December 11, 2025, becoming a market focus [4].

1. Price and Trading Volume Performance
   : As of December 2, 2025, the stock price was HK$1.87, close to its 52-week high of HK$2.47 [0]. According to Yahoo Finance historical data, from December 11 to 15, 2025, the stock price fluctuated around HK$1.90, with a closing price of HK$1.86 on the 15th [3]. However, the trading volume was exceptionally low: on December 2, the volume was only 5,000 shares, far below the average volume of 358,871 shares [0]; on December 15, the volume further dropped to 280 shares [3], indicating extremely low trading activity and a lack of solid transaction support. Regarding key price levels: the support level is HK$1.80, and the resistance level is HK$2.47 (52-week high) [0].

2. Catalysts for Becoming a Hot Stock
   : The main reason is that the stock appeared on the Hong Kong Stock Surge List of the East Money App, showing a significant price increase on the day and attracting investors’ attention [4]. Additionally, the company recently announced the issuance of 304 million shares to independent third parties at HK$0.08 per share, raising approximately HK$24.35 million for general working capital [1].

3. Fundamental Status
   : The company’s fundamentals are weak. As of June 30, 2025, its revenue decreased by 34.7% year-on-year to RMB 710 million, with a net loss of RMB 26 million [2]. Meanwhile, there are no investment bank ratings within 90 days, indicating a lack of institutional recognition [0].

1. Obvious Speculative Characteristics
   : The stock price surge lacks fundamental support, with extremely low trading volume and mainly small orders; no large capital inflows, indicating strong speculation [0].
2. Prominent Liquidity Risk
   : Extremely low trading volume indicates insufficient market liquidity, making the stock vulnerable to manipulation [0].
3. Information Risk Exists
   : Some financial data tools cannot obtain real-time quotes and historical trading data for this stock, which may involve risks such as suspension, delisting, or data service interruption [4].

1. Fundamental Risk
   : The company’s revenue and profits continue to decline, with weak fundamentals that cannot support the current stock price [2].
2. Speculative Volatility Risk
   : The stock price increase lacks transaction support and may experience significant fluctuations or even corrections [0].
3. Liquidity Risk
   : Extremely low trading volume may lead to difficulty in closing positions for investors [0].
4. Information Gap Risk
   : Difficulty in obtaining data makes it hard for investors to fully understand the company’s situation [4].

No clear investment opportunities have been identified so far; the stock price increase is mainly driven by short-term speculative factors and lacks fundamental support.

Grand Health International (02211.HK) has recently attracted attention due to appearing on the Hong Kong Stock Surge List of the East Money App, but it has obvious risk characteristics: weak fundamentals, extremely low trading volume, strong speculation, insufficient liquidity, and information gap risks. Investors should fully understand these risks and carefully evaluate their investment decisions.

Key price levels to watch:

• Support level: HK$1.80 [0]
• Resistance level: HK$2.47 (52-week high) [0]